Sunday, December 21, 2014 Last update: Yesterday, 8:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Generex Biotechnology Corporation

News articles for Generex Biotechnology Corporation:

Wednesday, December 17, 2014

Tuesday, November 18, 2014

  • Generex Announces Collaboration on Medicinal Cannabis
    WORCESTER, Mass. and TORONTO, Nov. 18, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) to license the Company's proprietary RapidMist(TM) drug delivery technologies to CannScience Innovations Inc. (CannScience) for the delivery of medicinal ... read more

Tuesday, November 11, 2014

Monday, October 27, 2014

Thursday, October 23, 2014

Tuesday, October 21, 2014

  • Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express
    WORCESTER, Mass. and TORONTO, Oct. 21, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that its wholly owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has issued a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine. Antigen Express has a proprietary technology ... read more

Tuesday, October 7, 2014

  • Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine
    WORCESTER, Mass. and TORONTO, Oct. 7, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today responded to a recent article posted to the Seeking Alpha website (http://seekingalpha.com/article/2533015-with-ebola-looming-when-will-the-defense-department-get-around-to-generex) regarding the need for an Ebola vaccine and the importance of providing funding for small companies with technologies applicable ... read more

Monday, September 22, 2014

  • Generex Collaborates with University Health Network for Buccal Insulin Project
    WORCESTER, Mass. and TORONTO, Sept. 22, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has entered into a collaboration with University Health Network (UHN) pursuant to which UHN's Centre for Molecular Design and Preformulations (CMDP) will spearhead the Company's buccal insulin refinement project. ... read more

Wednesday, September 3, 2014

  • Generex / Antigen Express to Participate in BioPharm America(TM) 2014
    WORCESTER, Mass. and TORONTO, Sept. 3, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be participating in the 7(th) Annual International Partnering Conference BioPharm America(TM) 2014 being held September 22-24 in Boston. The conference is ... read more

Wednesday, August 6, 2014

  • Generex Announces Publication of AE37 Prostate Cancer Vaccine Study
    WORCESTER, Mass. and TORONTO, Aug. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study demonstrates an association between a specific ... read more